Twist Bioscience (TWST) Cash from Investing Activities (2017 - 2025)

Twist Bioscience (TWST) has disclosed Cash from Investing Activities for 9 consecutive years, with -$9.9 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities fell 546.68% to -$9.9 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$33.2 million through Dec 2025, down 278.01% year-over-year, with the annual reading at -$24.8 million for FY2025, 706.32% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$9.9 million at Twist Bioscience, up from -$12.4 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $104.6 million in Q2 2021, with the low at -$226.6 million in Q4 2021.
  • Average Cash from Investing Activities over 5 years is -$900400.0, with a median of -$1.4 million recorded in 2024.
  • The sharpest move saw Cash from Investing Activities skyrocketed 409.61% in 2023, then crashed 1221.66% in 2025.
  • Over 5 years, Cash from Investing Activities stood at -$226.6 million in 2021, then surged by 96.92% to -$7.0 million in 2022, then soared by 159.75% to $4.2 million in 2023, then crashed by 136.88% to -$1.5 million in 2024, then tumbled by 546.68% to -$9.9 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$9.9 million, -$12.4 million, and -$9.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.